microbiome
It will use the funds to deepen its presence across Asia.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
The company, formerly named Thryve, also hired a new CEO and a chief product officer.
The partnership expands on the companies’ earlier collaboration announced in late 2019.
Vivante Health's offering includes at-home testing and a 24-7 care team support line.
DayTwo's metagenomics and gut microbiome database helps connect diabetics and others with evidence-based "food-as-medicine" treatment regimens, explains Josh Stevens, the company's president.
The funding will support the Israeli company's push into US markets.
The fate of the company's recently-announced research partnerships is unclear.